Actively Recruiting
Effects of Lactobacillus Paracasei LPB27 on Gut Microbiota and Immune Development in Healthy Infants Aged 0 to 6 Months
Led by BYHEALTH Co., LTD · Updated on 2026-10-26
370
Participants Needed
1
Research Sites
6 weeks
Total Duration
AI-Summary
What This Trial Is About
Researchers are studying the effects of the probiotic Lacticaseibacillus paracasei LPB27 on healthy infants aged 0 to 6 months. The study aims to evaluate how this probiotic may influence immune function, growth, development, and the composition of gut microbiota. It also looks at secondary effects such as stool characteristics and digestive symptoms like bloating, diarrhea, and abdominal pain. Participants are divided into three groups one group takes a daily 1-gram sachet of the probiotic for 84 days, providing at least 1 x 1010 colony-forming units. Another group receives a daily 1-gram sachet of maltodextrin as a placebo for the same period, and the third group is observed without any supplement. The probiotic or placebo powder can be mixed with water below 40C or added to milk before consumption. During the study, infants will be monitored at baseline, 12 weeks, and 24 weeks to measure fecal secretory immunoglobulin A sIgA, body weight, length, head circumference, and gut microbiota composition. Secondary measures include stool amount and occurrences of abdominal bloating, diarrhea, and pain, as well as fecal short-chain fatty acid concentration. This study involves a follow-up period extending to 24 weeks to assess these outcomes.
CONDITIONS
Brief Title
Study on the Effects of Probiotic on Infant Gut Microbiota and Immune Regulation
Research Team
M
Ming Li
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here